Abstract 3195: Preclinical development of SENTI-202, an off-the-shelf logic gated CAR-NK cell therapy, for the treatment of CD33/FLT3+ hematologic malignancies including AML von Gonzalez, Alba, Hong, Enping, Yucel, Gozde, Leitner, Elizabeth, Chinta, Pearley, Deng, Han, Li, Ian, Lam, Alice, Bakir, Abla, Lee, Brandon, Chakraborty, Papia, Blanco, Carmina, Lee, Chen-Ting, Almudhfar, Niran, Tian, Mengxi, Song, Wenqi, Banicki, Andrew, Contreras, Otto, Gieldin, Martin, Garrison, Brian, Lu, Timothy K., Rajangam, Kanya

Volltext